Chemotherapy Induces Cancer-Fighting B Cells

Cell
Zhida Liu, Yang-Xin Fu

Abstract

Tumor-infiltrating B cells are heterogeneous, and their roles in tumor immunity are controversial. In this issue of Cell, Lu and colleagues demonstrate that chemotherapy-induced complement signals promote the generation of ICOSL+B cells, which enhance tumor-specific T cell responses.

References

Apr 18, 2017·Cellular & Molecular Immunology·Haidong TangYang-Xin Fu
Jun 20, 2017·Trends in Cancer·Grace J YuenShiv Pillai
May 17, 2019·Nature Reviews. Cancer·Catherine Sautès-FridmanWolf Herman Fridman
Nov 2, 2019·Nature Reviews. Cancer·Lubka T RoumeninaWolf Herman Fridman
Dec 18, 2019·Cellular & Molecular Immunology·Zhida LiuYang-Xin Fu
Jan 17, 2020·Nature·Beth A HelminkJennifer A Wargo
Jan 17, 2020·Nature·Florent PetitprezWolf H Fridman

❮ Previous
Next ❯

Citations

Nov 4, 2020·Cellular & Molecular Immunology·Sterre T PaijensHans W Nijman
Jul 23, 2020·Life Sciences·Keywan Mortezaee
Jun 8, 2021·Frontiers in Immunology·Kewei LiuKe Jiang
Aug 7, 2021·Cancer Immunology, Immunotherapy : CII·Nafiseh BehranvandReza Falak

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell eTOC

Cell is a scientific journal publishing research across a broad range of disciplines within the life sciences field. Discover the latest research from Cell here.